New onset of autoimmune diseases following COVID-19 diagnosis
There is growing evidence that coronavirus disease 2019 (COVID-19) can lead to a
dysregulation of the immune system with the development of autoimmune phenomena. The …
dysregulation of the immune system with the development of autoimmune phenomena. The …
[PDF][PDF] Skeletal muscles and Covid-19: a systematic review of rhabdomyolysis and myositis in SARS-CoV-2 infection
Skeletal muscles and Covid-19: a systematic review of rhabdomyolysis and myositis in
SARS-CoV-2 infection Page 1 Clinical and Experimental Rheumatology 2022 Clinical and …
SARS-CoV-2 infection Page 1 Clinical and Experimental Rheumatology 2022 Clinical and …
The musculoskeletal involvement after mild to moderate COVID-19 infection
COVID-19, a disease caused by the novel coronavirus SARS-CoV-2, has been drastically
affecting the daily lives of millions of people. COVID-19 is described as a multiorgan disease …
affecting the daily lives of millions of people. COVID-19 is described as a multiorgan disease …
What do we need to know about musculoskeletal manifestations of COVID-19?: a systematic review
RE Pires, IGN Reis, GS Waldolato, DD Pires… - JBJS …, 2022 - journals.lww.com
What Do We Need to Know About Musculoskeletal Manifestations... : JBJS Reviews What Do
We Need to Know About Musculoskeletal Manifestations of COVID-19?: A Systematic Review …
We Need to Know About Musculoskeletal Manifestations of COVID-19?: A Systematic Review …
COVID-19 and neurologic manifestations: a synthesis from the child neurologist's corner
C Valderas, G Méndez, A Echeverría, N Suarez… - World Journal of …, 2022 - Springer
Abstract Background Since December 2019, the SARS-CoV-2 virus has been a global
health issue. The main clinical presentation of this virus is a flu-like disease; however …
health issue. The main clinical presentation of this virus is a flu-like disease; however …
Clinical and molecular characterization of a rare case of BNT162b2 mRNA COVID-19 vaccine-associated myositis
Initial clinical trials and surveillance data have shown that the most commonly administered
BNT162b2 COVID-19 mRNA vaccine is effective and safe. However, several cases of mRNA …
BNT162b2 COVID-19 mRNA vaccine is effective and safe. However, several cases of mRNA …
Epidemiology of the idiopathic inflammatory myopathies
The idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of systemic
autoimmune diseases that affect the skeletal muscles and can also involve the skin, joints …
autoimmune diseases that affect the skeletal muscles and can also involve the skin, joints …
Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review
Abstract Anti-MDA5 (Melanoma differentiation-associated protein 5) myositis is a rare
subtype of dermatomyositis (DM) characterized by distinct ulcerative, erythematous …
subtype of dermatomyositis (DM) characterized by distinct ulcerative, erythematous …
COVID‐19 vaccination in autoimmune diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies
Abstract Introduction/Aims In this study we investigated COVID‐19 vaccination–related
adverse events (ADEs) 7 days postvaccination in patients with idiopathic inflammatory …
adverse events (ADEs) 7 days postvaccination in patients with idiopathic inflammatory …
Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress
X Lu, Q Peng, G Wang - Nature Reviews Rheumatology, 2024 - nature.com
Anti-melanoma differentiation-associated protein 5 (MDA5) antibody-positive
dermatomyositis (MDA5-DM) is a subtype of dermatomyositis. Although the aetiology and …
dermatomyositis (MDA5-DM) is a subtype of dermatomyositis. Although the aetiology and …